Last $427.64 USD
Change Today +3.85 / 0.91%
Volume 1.4M
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert E. Landry Jr.

Chief Financial Officer and Senior Vice President of Finance, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

50$12,613,135
As of Fiscal Year 2013

Background*

Mr. Robert E. Landry Jr., also known as Bob, Jr. has been Senior Vice President of Finance at Regeneron Pharmaceuticals, Inc since September 2013 and its Chief Financial Officer since October 1, 2013. Mr. Landry has responsibility for all financial functions, including Controller's, Treasury, Financial Planning, Tax, and Internal Audit. In his new role, Mr. Goldberg continue to have responsibility for Alliance Management and various administrative functions. He served ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BBA
University of Notre Dame

Other Affiliations*

Annual Compensation*

Salary$144,231
Bonus$50,000
Total Annual Compensation$194,231

Stock Options*

Restricted Stock Awards$1,363,500
All Other Compensation$1,130
Unexercisable Options80,000
Unexercisable Options Value$203,200
Total Value of Options$203,200
Total Number of Options80,000

Total Compensation*

Total Annual Cash Compensation$195,361
Total Short Term Compensation$194,231
Other Long Term Compensation$1,364,630
Total Calculated Compensation$12,613,135
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $427.64 USD +3.85

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Leonard Bell M.D.Co-Founder, Chairman of the Board and Chief Executive Officer
Alexion Pharmaceuticals, Inc.
$1.2M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB S.A.
€2.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.